WebDisclosure WebDisclosure
Basculer en Français
10761 Companies
231282 Keywords
159692 Articles
122953 Press releases
Headlines Articles Press releases Urban-gro, Inc Remove
  1. Home
  2. Companies
  3. Urban-gro, Inc
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • PRESS RELEASE

    published on 03/13/2024 at 13:00, 2 years 4 months ago

    urban-gro, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 27, 2024

    urban-gro, Inc. to announce Q4 and full year 2023 financial results on March 27, 2024, with a conference call and webcast for stakeholders. Learn more at https://ir.urban-gro.com/news-events/
    Financial Results Conference Call 2023 Webcast Urban-gro Inc
    Logo of Urban-gro, Inc.
  • PRESS RELEASE

    published on 09/27/2023 at 11:01, 2 years 9 months ago

    Original-Research: urban-gro, Inc (von First Berlin Equity Research GmbH): Kaufen

    Logo of Urban-gro, Inc
  • PRESS RELEASE

    published on 08/17/2023 at 10:01, 2 years 11 months ago

    Original-Research: urban-gro, Inc (von First Berlin Equity Research GmbH): Kaufen

    Logo of Urban-gro, Inc
  • PRESS RELEASE

    published on 06/27/2023 at 12:11, 3 years ago

    Original-Research: urban-gro, Inc (von First Berlin Equity Research GmbH): Kaufen

    Logo of Urban-gro, Inc
Previous page
1 ... 11 12
Accesswire
  • Published on 07/22/2026 at 15:00, 3 hours 39 minutes ago

    Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya

  • Published on 07/22/2026 at 15:00, 3 hours 39 minutes ago

    Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)

  • Published on 07/22/2026 at 14:50, 3 hours 49 minutes ago

    Hillcrest Enters AI Datacenter Ecosystem

  • Published on 07/22/2026 at 14:35, 4 hours 4 minutes ago

    Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026

  • Published on 07/22/2026 at 14:30, 4 hours 9 minutes ago

    As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola

View all ACCESSWIRE
EQS Group
  • Published on 07/22/2026 at 18:28, 11 minutes ago

    EQS-Adhoc: Dürr Aktiengesellschaft: Improvement of efficiency at BBS Automation, preliminary figures Q2 2026

  • Published on 07/22/2026 at 18:19, 20 minutes ago

    EQS-Adhoc: CHAPTERS Group AG: Capital Increase from Authorized Capital Resolved

  • Published on 07/22/2026 at 18:01, 38 minutes ago

    Online broker flatexDEGIRO further expands record results and increases Net Income by 55 Percent

  • Published on 07/22/2026 at 18:00, 39 minutes ago

    BIOSYNEX SA: CHIFFRE D’AFFAIRES DU 1er SEMESTRE 2026 : 44,1 M€ - PERSPECTIVES

  • Published on 07/22/2026 at 18:00, 39 minutes ago

    Leclanché tient son Assemblée générale extraordinaire de juillet 2026

View all EQS
Les Echos
  • Published on 07/22/2026 at 18:19, 20 minutes ago

    Covivio place avec succès 500 M€ d’obligations vertes à 7 ans

  • Published on 07/22/2026 at 18:19, 20 minutes ago

    Covivio successfully places €500 million of 7-year European Green Bonds

  • Published on 07/22/2026 at 17:45, 54 minutes ago

    Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).

  • Published on 07/22/2026 at 17:45, 54 minutes ago

    Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).

  • Published on 07/22/2026 at 17:40, 59 minutes ago

    Report on share repurchases from 15 to 21 July 2026

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy